Efficacy and safety of recombinant human epidermal growth factor combined with fractional carbon dioxide laser for facial atrophic acne scars: a systematic review and meta-analysis of randomized trials

Shuyu Zhou, Chenqi Guo, Jingbo Zhai, Yu Zhang · 2026

Read Efficacy and safety of recombinant human epidermal growth factor combined with fractional carbon dioxide laser for facial atrophic acne scars: a systematic review and meta-analysis of randomized trials by Shuyu Zhou, Chenqi Guo, Jingbo Zhai, Yu Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194242.txt.

Description

Shuyu Zhou is first author on a 2026 systematic review and meta-analysis of a combined treatment for sunken facial acne scars. Fractional carbon dioxide laser resurfacing is a standard option, and adding recombinant human epidermal growth factor, a lab-made skin growth protein, is increasingly practiced. Whether the pairing beats laser alone needed gathering.

Searching eight databases to July twenty twenty-five, the authors included twelve randomized trials with one thousand and forty-four patients, all in China. The combination improved scar scores more than laser alone and shortened crusting time. Side effects, especially darkening of skin, were less frequent with the combination. Evidence certainty, though, ranged from very low to moderate, so larger, stronger trials are needed.

Catalog record

CREATORShuyu Zhou, Chenqi Guo, Jingbo Zhai, Yu Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13194242

Browse the full library · About the Tower of Babel